86 related articles for article (PubMed ID: 2241185)
1. [Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].
Fukuoka M; Miyazaki T; Yoshida Y; Hattori M; Niitani H; Nakamura T; Hirota Y; Ohta K; Tanaka M; Suzuoki Y
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2213-9. PubMed ID: 2241185
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].
Tatsumi N; Yamada K; Ohshima T; Nakamura T; Ohno R; Masaoka T; Kimura I; Kimura K
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2387-95. PubMed ID: 2260876
[TBL] [Abstract][Full Text] [Related]
3. [A case of complete remission from acute unclassified leukemia achieved by using a prodrug of ara C, stearyl-ara-CMP (YNK01)].
Nishikawa M; Morita K; Komada F; Uemura Y; Kageyama S; Minami N; Deguchi K; Shirakawa S
Gan No Rinsho; 1990 Oct; 36(12):2204-9. PubMed ID: 2232191
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
Nagahata T; Shibasaki C; Ishii T; Uchida T; Arakawa M; Kusama K; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1437-45. PubMed ID: 2389942
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of Ara-CMP-Stearate (YNK01): phase I study of the oral Ara-C derivative.
Schleyer E; Braess J; Ramsauer B; Unterhalt M; Kaufmann C; Wilde S; Schüssler M; Hiddemann W
Leukemia; 1995 Jun; 9(6):1085-90. PubMed ID: 7596174
[TBL] [Abstract][Full Text] [Related]
6. [Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma].
Suto T; Yoshida Y; Sakata Y; Ono T; Yoshida T; Yamada N; Chida N; Oohira H
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1933-8. PubMed ID: 9797816
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
Ueda T; Kamiya K; Urasaki Y; Wataya S; Kawai Y; Tsutani H; Sugiyama M; Nakamura T
Cancer Res; 1994 Jan; 54(1):109-13. PubMed ID: 8261429
[TBL] [Abstract][Full Text] [Related]
8. Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.
Braess J; Freund M; Hanauske A; Heil G; Kaufmann C; Kern W; Schüssler M; Hiddemann W; Schleyer E
Leukemia; 1998 Oct; 12(10):1618-26. PubMed ID: 9766508
[TBL] [Abstract][Full Text] [Related]
9. [A pharmacokinetic study of the value of oral cytarabine ocfosfate in the treatment of hematological malignancies].
Ueda Y; Mori S; Ito T; Maesako Y; Konishi H; Yagiri Y
Rinsho Ketsueki; 1998 May; 39(5):348-54. PubMed ID: 9637884
[TBL] [Abstract][Full Text] [Related]
10. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
Beran M; Jeha S; O'Brien S; Estey E; Vitek L; Zurlo MG; Rios MB; Keating M; Kantarjian H
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2377-84. PubMed ID: 9815637
[TBL] [Abstract][Full Text] [Related]
11. [Clinical efficacy of YNK 01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) in patients with polycythemia vera].
Naito K; Kitaori K; Morishima Y
Gan To Kagaku Ryoho; 1993 May; 20(7):973-6. PubMed ID: 8489306
[No Abstract] [Full Text] [Related]
12. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
[TBL] [Abstract][Full Text] [Related]
13. Treatment of myelodysplastic syndromes with orally administered 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate.
Ohno R; Tatsumi N; Hirano M; Imai K; Mizoguchi H; Nakamura T; Kosaka M; Takatsuki K; Yamaya T; Toyama K
Oncology; 1991; 48(6):451-5. PubMed ID: 1749580
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of myelodysplastic syndromes (MDS) with oral administration of N4-palmitoyl-1-beta-D-arabinofuranosyl cytosine (PLAC)].
Ohno R; Kimura K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1205-8. PubMed ID: 3382195
[TBL] [Abstract][Full Text] [Related]
15. [Plasma concentration of cytosine arabinoside (Ara-C) in the elderly patients with hematological malignancy treated by Ara-C or cytarabine ocfosfate (SPAC)].
Tsutsumi H; Kumakawa T; Hirai M; Kikukawa M; Arie Y; Mori M; Kodo H; Nakamura N; Murai Y; Mizutani R
Nihon Ronen Igakkai Zasshi; 1995 Mar; 32(3):190-4. PubMed ID: 7596061
[TBL] [Abstract][Full Text] [Related]
16. [Oral administration of cytarabine ocfosfate and ondansetron hydrochloride in patients with acute myeloid leukemia who can not be treated with intensive chemotherapy:--attempt to make their quality of life better].
Yano K; Matsui H; Fujisawa S
Gan To Kagaku Ryoho; 1998 Feb; 25(3):427-30. PubMed ID: 9492840
[No Abstract] [Full Text] [Related]
17. [Successful treatment of acute myelogenous leukemia in an elderly patient with cytarabine ocfosfate].
Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M; Fujita N; Miyazaki S
Gan To Kagaku Ryoho; 1994 Mar; 21(4):535-8. PubMed ID: 8129396
[TBL] [Abstract][Full Text] [Related]
18. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
[TBL] [Abstract][Full Text] [Related]
19. [Clinical effects of stearyl-ara-CMP (YNK-01) on chronic hematologic malignancies].
Im T; Ota K; Ohira H; Yasui Y; Nakao Y; Furukawa Y; Inoue K; Yamane T; Hiyoshi M; Kishida T
Gan To Kagaku Ryoho; 1991 Jan; 18(1):139-42. PubMed ID: 1987896
[No Abstract] [Full Text] [Related]
20. [Phase I clinical study of TT-62. Research group of TT-62].
Taguchi T; Furue H; Niitani H; Ohta K; Tsukagoshi S; Wakui A; Hasegawa K; Nakao I; Ohashi Y; Tominaga T
Gan To Kagaku Ryoho; 1993 Feb; 20(2):241-6. PubMed ID: 8434962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
